AHIP Applauds FDA For Emergency Use Authorization Of The Nation’s First COVID-19 Vaccine

posted by AHIP

on December 12, 2020

Washington, D.C. – (December 12, 2020) – Matt Eyles, president and CEO of America’s Health Insurance Plans (AHIP) issued this statement following the Food and Drug Administration’s (FDA) emergency use authorization of the nation’s first COVID-19 vaccine:

Vaccines save lives and are essential to overcoming the COVID-19 crisis. We applaud the FDA for its swift award of emergency use authorization for America’s first COVID-19 vaccine to power our nation toward recovery. The agency’s robust, rapid process and commitment to scientific rigor have been essential to the availability of a safe and effective vaccine that Americans deserve.

This vaccine is an important example of how essential strong partnerships are between the public sector and private market. Together, we can conquer obstacles and speed innovation to improve health and saves lives. Health insurance providers will continue to work with federal, state and local leaders to execute successful strategies to ensure Americans get this much-needed vaccine, particularly in communities of color where health inequities have led to more dire consequences from the virus.  We will also work with key leaders and other organizations to educate consumers and our enrollees on the importance of getting vaccinated to encourage widespread uptake and halt the spread of the disease. Working together, we can and will overcome the COVID-19 crisis.

About AHIP

AHIP is the national association whose members provide coverage for health care and related services to hundreds of millions of Americans every day. Through these offerings, we improve and protect the health and financial security of consumers, families, businesses, communities and the nation. We are committed to market-based solutions and public-private partnerships that improve affordability, value, access, and well-being for consumers. Visit for more information.